Hypofractionated stereotactic radiotherapy for large brain metastases
Phase 2
- Conditions
- Brain metastases
- Registration Number
- JPRN-UMIN000010112
- Lead Sponsor
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient with dissemination. 2) There are other malignanicies. 3) Patients in pregnancy. 4) Unknown primary cancer 5) Patient with schizoaffective disorder or other severe psychiatric disorder. 6) Patients treated with steroid for one or more months. 7) Brain metastases of malignant melanoma, sarcoma, lymphoma or small cell lung cancer. 8) Responsible doctors judged the patient inappropriate for the trial. 9) No history of craniotomy or radiotherapy to the brain
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival rate at 6 months
- Secondary Outcome Measures
Name Time Method 1) Performance status and activity of daily living at 3, 6 and 12 months 2) Toxicity 3) Local control rate at 6 and 12 months 4) Occurrence of new brain metastases 6 and 12 months